Margaret M. Dunne - Concepedia

Author

Margaret M. Dunne

Kaiser Permanente ORCID

Also Known As

Dunne, Margaret M, Jillian P. Rhoads, Julius Timbol, Margaret Dunne, Margaret M Dunne, Margaret M. Dunne

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Kaiser Permanente Regenstrief Institute Intermountain Healthcare University of Colorado Anschutz Medical Campus HealthPartners

About

Margaret M. Dunne is an author at Kaiser Permanente specializing in public health, medicine, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	172
2	Public Health	4	4	172
3	Epidemiology	3	3	158
4	Global Health	1	1	31
5	Immunology	1	1	96

Margaret M. Dunne

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, MMWR Morbidity and Mortality Weekly Report	2022	427
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 Peter J. Embí, Matthew E. Levy, Allison L. Naleway, MMWR Morbidity and Mortality Weekly Report	2021	188
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 Ruth Link‐Gelles, Matthew E. Levy, Manjusha Gaglani, MMWR Morbidity and Mortality Weekly Report	2022	124
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, MMWR Morbidity and Mortality Weekly Report	2022	109
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023 Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyAdvisory CommitteeVaccine HesitancyCovid-19	2023	96
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 Amadea Britton, Peter J. Embí, Matthew E. Levy, MMWR Morbidity and Mortality Weekly Report	2022	85
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods Ruth Link‐Gelles, Matthew E. Levy, Karthik Natarajan, JAMA Network Open	2023	80
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022 Karthik Natarajan, Namrata Prasad, Kristin Dascomb, MMWR Morbidity and Mortality Weekly Report	2022	50
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, MMWR Morbidity and Mortality Weekly Report	2023	49
The World Health Organization’s Disease Outbreak News: A retrospective database Colin J. Carlson, Matthew R Boyce, Margaret M. Dunne, PLOS Global Public Health World Health OrganizationEpidemiological DynamicDisease OutbreakCovid-19Public Health	2023	31

Page 1